Single- and Multiple-Dose Pharmacokinetics and Pharmacodynamics of PN-943, a Gastrointestinal-Restricted Oral Peptide Antagonist of α4β7, in Healthy Volunteers.
Saved in:
| Title: | Single- and Multiple-Dose Pharmacokinetics and Pharmacodynamics of PN-943, a Gastrointestinal-Restricted Oral Peptide Antagonist of α4β7, in Healthy Volunteers. |
|---|---|
| Authors: | Modi NB; Protagonist Therapeutics, Inc, Newark, California, USA., Cheng X; Protagonist Therapeutics, Inc, Newark, California, USA., Mattheakis L; Protagonist Therapeutics, Inc, Newark, California, USA., Hwang CC; Protagonist Therapeutics, Inc, Newark, California, USA., Nawabi R; Protagonist Therapeutics, Inc, Newark, California, USA., Liu D; Protagonist Therapeutics, Inc, Newark, California, USA., Gupta S; Protagonist Therapeutics, Inc, Newark, California, USA. |
| Source: | Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2021 Nov; Vol. 10 (11), pp. 1263-1278. Date of Electronic Publication: 2021 May 04. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33942566 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Single- and Multiple-Dose Pharmacokinetics and Pharmacodynamics of PN-943, a Gastrointestinal-Restricted Oral Peptide Antagonist of α4β7, in Healthy Volunteers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Modi+NB%22">Modi NB</searchLink>; Protagonist Therapeutics, Inc, Newark, California, USA.<br /><searchLink fieldCode="AU" term="%22Cheng+X%22">Cheng X</searchLink>; Protagonist Therapeutics, Inc, Newark, California, USA.<br /><searchLink fieldCode="AU" term="%22Mattheakis+L%22">Mattheakis L</searchLink>; Protagonist Therapeutics, Inc, Newark, California, USA.<br /><searchLink fieldCode="AU" term="%22Hwang+CC%22">Hwang CC</searchLink>; Protagonist Therapeutics, Inc, Newark, California, USA.<br /><searchLink fieldCode="AU" term="%22Nawabi+R%22">Nawabi R</searchLink>; Protagonist Therapeutics, Inc, Newark, California, USA.<br /><searchLink fieldCode="AU" term="%22Liu+D%22">Liu D</searchLink>; Protagonist Therapeutics, Inc, Newark, California, USA.<br /><searchLink fieldCode="AU" term="%22Gupta+S%22">Gupta S</searchLink>; Protagonist Therapeutics, Inc, Newark, California, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101572899%22">Clinical pharmacology in drug development</searchLink> [Clin Pharmacol Drug Dev] 2021 Nov; Vol. 10 (11), pp. 1263-1278. <i>Date of Electronic Publication: </i>2021 May 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101572899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2160-7648 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222160763X%22">2160763X </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Drug Dev <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33942566 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cpdd.946 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1263 Titles: – TitleFull: Single- and Multiple-Dose Pharmacokinetics and Pharmacodynamics of PN-943, a Gastrointestinal-Restricted Oral Peptide Antagonist of α4β7, in Healthy Volunteers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Modi NB – PersonEntity: Name: NameFull: Cheng X – PersonEntity: Name: NameFull: Mattheakis L – PersonEntity: Name: NameFull: Hwang CC – PersonEntity: Name: NameFull: Nawabi R – PersonEntity: Name: NameFull: Liu D – PersonEntity: Name: NameFull: Gupta S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2021 Nov Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 2160-7648 Numbering: – Type: volume Value: 10 – Type: issue Value: 11 Titles: – TitleFull: Clinical pharmacology in drug development Type: main |
| ResultId | 1 |